Peter Valent
Department of Internal Medicine I
Division of Hematology & Hemostaseology
Medical University of Vienna
Vienna
Austria
Name/email consistency: high
- Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Valent, P., Bain, B.J., Bennett, J.M., Wimazal, F., Sperr, W.R., Mufti, G., Horny, H.P. Leuk. Res. (2012)
- CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin. Herrmann, H., Cerny-Reiterer, S., Gleixner, K.V., Blatt, K., Herndlhofer, S., Rabitsch, W., Jäger, E., Mitterbauer-Hohendanner, G., Streubel, B., Selzer, E., Schwarzinger, I., Sperr, W.R., Valent, P. Haematologica (2012)
- The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells. Herrmann, H., Kneidinger, M., Cerny-Reiterer, S., Rulicke, T., Willmann, M., Gleixner, K.V., Blatt, K., Hormann, G., Peter, B., Samorapoompichit, P., Pickl, W., Bharate, G.Y., Mayerhofer, M., Sperr, W.R., Maeda, H., Valent, P. Curr. Cancer. Drug. Targets (2012)
- Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536. Peter, B., Gleixner, K.V., Cerny-Reiterer, S., Herrmann, H., Winter, V., Hadzijusufovic, E., Ferenc, V., Schuch, K., Mirkina, I., Horny, H.P., Pickl, W.F., Müllauer, L., Willmann, M., Valent, P. Haematologica (2011)
- How I treat patients with advanced systemic mastocytosis. Valent, P., Sperr, W.R., Akin, C. Blood (2010)
- Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. Valent, P., Cerny-Reiterer, S., Herrmann, H., Mirkina, I., George, T.I., Sotlar, K., Sperr, W.R., Horny, H.P. Best. Pract. Res. Clin. Haematol (2010)
- Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor? Valent, P. Eur. J. Clin. Invest. (2010)
- Role of interleukins in the regulation of basophil development and secretion. Valent, P., Dahinden, C.A. Curr. Opin. Hematol. (2010)
- Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Valent, P. Blood Rev. (2009)
- Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes. Valent, P., Hofmann, W.K., Büsche, G., Sotlar, K., Horny, H.P., Haase, D., Haferlach, T., Kern, W., Bettelheim, P., Baumgartner, C., Sperr, W.R., Nösslinger, T., Wimazal, F., Giagounidis, A.A., Lübbert, M., Krieger, O., Kolb, H.J., Stauder, R., Pfeilstöcker, M., Gattermann, N., Fonatsch, C., Aul, C., Germing, U. Ann. Hematol. (2009)
- Update on genetic and molecular markers associated with myelodysplastic syndromes. Valent, P., Wieser, R. Leuk. Lymphoma (2009)
- Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions. Valent, P., Horny, H.P. Eur. J. Clin. Invest. (2009)
- Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Valent, P., Lechner, K. Wien. Klin. Wochenschr. (2008)
- Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: a hypothesis supported by unique case reports. Valent, P. Leuk. Res. (2008)
- Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease. Valent, P. Br. J. Haematol. (2008)
- Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform. Valent, P., Lion, T., Wolf, D., Sillaber, C., Agis, H., Petzer, A., Lang, A., Kalhs, P., Geissler, D., Greil, R., Linkesch, W., Burgstaller, S., Thaler, J., Gastl, G. Wien. Klin. Wochenschr. (2008)
- Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform. Valent, P., Krieger, O., Stauder, R., Wimazal, F., Nösslinger, T., Sperr, W.R., Sill, H., Bettelheim, P., Pfeilstöcker, M. Eur. J. Clin. Invest. (2008)
- Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia. Valent, P., Deininger, M. Leuk. Lymphoma (2008)
- Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia. Valent, P., Agis, H., Sperr, W., Sillaber, C., Horny, H.P. Leuk. Lymphoma (2008)
- Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Valent, P., Horny, H.P., Bennett, J.M., Fonatsch, C., Germing, U., Greenberg, P., Haferlach, T., Haase, D., Kolb, H.J., Krieger, O., Loken, M., van de Loosdrecht, A., Ogata, K., Orfao, A., Pfeilstöcker, M., Rüter, B., Sperr, W.R., Stauder, R., Wells, D.A. Leuk. Res. (2007)
- Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W.R., Kluin-Nelemans, H.C., Hamdy, N.A., Lortholary, O., Robyn, J., van Doormaal, J., Sotlar, K., Hauswirth, A.W., Arock, M., Hermine, O., Hellmann, A., Triggiani, M., Niedoszytko, M., Schwartz, L.B., Orfao, A., Horny, H.P., Metcalfe, D.D. Eur. J. Clin. Invest. (2007)
- Diagnostic evaluation and classification of mastocytosis. Valent, P. Immunol. Allergy. Clin. North. Am (2006)
- Use of interleukin-11 to stimulate platelet production in myelodysplastic syndromes. Valent, P. Leuk. Lymphoma (2006)
- Mastocytosis: pathology, genetics, and current options for therapy. Valent, P., Akin, C., Sperr, W.R., Mayerhofer, M., Födinger, M., Fritsche-Polanz, R., Sotlar, K., Escribano, L., Arock, M., Horny, H.P., Metcalfe, D.D. Leuk. Lymphoma (2005)
- On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts. Valent, P., Ghannadan, M., Akin, C., Krauth, M.T., Selzer, E., Mayerhofer, M., Sperr, W.R., Arock, M., Samorapoompichit, P., Horny, H.P., Metcalfe, D.D. Eur. J. Clin. Invest. (2004)
- The European Competence Network on Mastocytosis (ECNM). Valent, P., Arock, M., Bischoff, S.C., Bühring, H.J., Brockow, K., Escribano, L., Födinger, M., Grabbe, J., Hartmann, K., Henz, B.M., Horny, H.P., Kluin-Nelemans, H.C., Lima, M., Marone, G., Orfao, A., Parwaresch, R.M., Sillaber, C., Sotlar, K., Sperr, W.R., Triggiani, M., Van Doormaal, J.J., Wolff, K., Zuberbier, T. Wien. Klin. Wochenschr. (2004)
